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Abstract
Background The prevalence of recurrent laryngeal nerve
(RLN) injury is higher in repeat than in primary thyroid
operations. The use of intraoperative nerve monitoring
(IONM) as an aid in dissection of the scar tissue is believed
to minimize the risk of nerve injury. The aim of this study
was to examine whether the use of IONM in thyroid reo-
perations can reduce the prevalence of RLN injury.
Methods This was a retrospective cohort study of patients
who underwent thyroid reoperations with IONM versus
with RLN visualization, but without IONM. The database
of thyroid surgery was searched for eligible patients
(treated in the years 1993–2012). The primary outcomes
were transient and permanent RLN injury. Laryngoscopy
was used to evaluate and follow RLN injury.
Results The study group comprised 854 patients (139
men, 715 women) operated for recurrent goiter (n = 576),
recurrent hyperthyroidism (n = 36), completion thyroid-
ectomy for cancer (n = 194) or recurrent thyroid cancer
(n = 48), including 472 bilateral and 382 unilateral reo-
perations; 1,326 nerves at risk (NAR). A group of 306
patients (500 NAR) underwent reoperations with IONM
and 548 patients (826 NAR) had reoperations with RLN
visualization, but without IONM. Transient and permanent
RLN injuries were found respectively in 13 (2.6 %) and
seven (1.4 %) nerves with IONM versus 52 (6.3 %) and 20
(2.4 %) nerves without IONM (p = 0.003 and p = 0.202,
respectively).
Conclusions IONM decreased the incidence of transient
RLN paresis in repeat thyroid operations compared with
nerve visualization alone. The prevalence of permanent
RLN injury tended to be lower in thyroid reoperations with
IONM, but statistical validation of the observed differences
requires a sample size of 920 NAR per arm.
Introduction
Thyroid reoperations can be challenging, even for a highly
experienced thyroid surgeon, as visual identification of the
recurrent laryngeal nerve (RLN) is more difficult during
dissection of the scar tissues than in the virgin neck [1, 2].
The prevalence of RLN injury is higher in repeat than in
primary thyroid operations and it has been reported to
approach 12.5 % for transient events and 3.8 % for per-
manent events [1–11]. Unilateral RLN injury can diminish
quality of life due to a variety of symptoms related to voice
changes and subsequent limitations in physical, emotional
and social functioning, while bilateral RLN injury can be a
life-threatening complication leading to airway obstruction
[12]. Thus, it is not surprising that RLN injury is still a
major cause of litigation in endocrine surgery [13]. In
recent years, intraoperative nerve monitoring (IONM) has
been standardized and has gained more acceptance as an
addition to the gold standard of visual nerve identification
in thyroid and parathyroid surgery [14–18]. IONM is
believed by many surgeons to aid in RLN dissection in the
scar tissues of the neck, minimizing the risk of inadvertent
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nerve injury [14]. However, so far, this belief is not evi-
dence based [11]. A prospective randomised controlled
trial of RLN visualisation versus RLN visualisation plus
IONM in redo thyroid surgery is not readily feasible, jus-
tifying the use of evidence from cohort studies. The aim of
the present retrospective cohort study was to test the
hypothesis that the use of IONM in thyroid reoperations
can reduce the prevalence of RLN injury in comparison
with thyroid reoperations with RLN visual identification
alone.
Materials and methods
This was a retrospective cohort study of patients who
underwent thyroid reoperations at the Third Department of
General Surgery, Jagiellonian University Medical College,
Kraków, Poland. The prospectively collected database of
thyroid surgery was searched for eligible patients (treated
in the years 1993–2012). The study group comprised
patients who underwent reoperative thyroid surgery with
IONM. They were compared with patients who had thyroid
reoperations with RLN visual identification, but without
IONM. Laryngoscopy was mandatory in all patients before
reoperation and afterwards, and was used to evaluate and
follow RLN injury. All patients provided written informed
consent for the storage and use of their data.
The inclusion criteria were recurrent goitre, recurrent
hyperthyroidism, completion thyroidectomy for incidental
cancer in a patient after bilateral less than near-total thy-
roidectomy (or Dunhill operation), or recurrent thyroid
cancer. The exclusion criteria were contralateral goitre
recurrence in a patient after lobectomy, completion thy-
roidectomy for cancer in a patient after lobectomy, goitre
recurrence in the pyramidal lobe in a patient after total
thyroidectomy or incomplete clinical data or follow-up
information.
The primary outcome measures were transient and
permanent RLN injury. The secondary outcome measures
included the utility of IONM in mapping RLN in the scar
tissues of the neck and in predicting postoperative vocal
cord dysfunction: positive predictive value (PPV) and
negative predictive value (NPV).
The protocol of this study was approved by the Insti-
tutional Review Board.
Surgical technique
Surgeon-performed neck ultrasound was mandatory in all
patients before reoperation. It was used to identify the
dominant side of goitre recurrence (which was operated on
first), to identify if the pyramidal lobe remnant was present
and to evaluate thyroid remnant volume and lymph node
status.
All operations were performed on patients under general
anaesthesia by five experienced endocrine surgeons (MB,
AK, SC, MS, WN). The anaesthesia protocol included
intravenous midazolam premedication; induction with
fentanyl, thiopental and suxamethonium; endotracheal
intubation and sevoflurane maintenance. No other muscle
relaxants were used during the operations. A standard
cervicotomy with excision of the existing scar was per-
formed in all patients. A lateral approach was routinely
used for all cases. In operations without IONM, the first
step was visual identification of the RLN low in the neck
(below the crossing with the inferior thyroid artery). Once
the nerve was visually identified, it was carefully dissected
along its course towards the larynx. In operations with
IONM, the visual identification of the RLN was facilitated
via the IONM system, with the nerve mapping technique.
Once the nerve was visually identified, repeated stimula-
tions with the monopolar probe of the IONM system served
to trace the nerve path in the operative field and test its
functional integrity during dissection. In each patient, the
RLN was exposed and the branches of the superior and
inferior thyroid arteries were divided close to the thyroid
capsule (peripheral ligation). The characteristics of the
patients are presented in Table 1, while the extent of sur-
gery is presented in Table 2.
Table 1 Characteristics of patients
Characteristics With IONM Without IONM
n = 306 n = 548
Ratio (female:male) 247:59 440:108
Mean age ± SD (years) 54.6 ± 13.2 54.0 ± 13.6
Preoperative diagnosis
Non-toxic multinodular goitre 220 (71.9) 356 (65.0)
Toxic multinodular goitre 9 (2.9) 17 (3.1)
Graves’ disease 2 (0.7) 8 (1.5)
Differentiated thyroid cancer 70 (22.9) 161 (29.4)
Medullary thyroid cancer 5 (1.6) 6 (1.1)
Number of previous operations
1 258 485
2 29 59
3 1 4
Preoperative RLN palsy k 7 (2.3) 11 (2.0)
Data are presented as numbers (%) unless otherwise indicated. k
calculated for patients
IONM intraoperative nerve monitoring, RLN recurrent laryngeal
nerve, SD standard deviation
 p = 0.038; p = 0.040 all other differences were not significant
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IONM technique
During this study period, two differing neuromonitoring
systems were used at our unit. The Neurosign 100 system
(Inomed, Teningen, Germany) was in use between 2004
and 2007, while the NIM 2.0 followed by the NIM 3.0
(Medtronic, Jacksonville, USA) was in use between 2008
and 2012. The Neurosing 100 system operated with
needle electrodes. After identification of the cricoid and
thyroid cartilage, the ipsilateral vocal muscle was impaled
with the bipolar recording electrode through the cricothy-
roid ligament. The neutral electrode was placed in the
sternocleidomastoid muscle. The proper placement of the
electrodes was confirmed by an impedance meter of the
circuit in the patient in the final operating position. A hand-
held bipolar, concentric stimulating probe was used with a
current amplitude of 1 (range 0.5–1.0) mA (depending on
the RLN threshold) and 3-Hz impulses of 200 ms each for
1–2 s. The electrical field response of the muscle was
documented as an acoustic signal. The NIM system
operated with surface electrodes integrated with an endo-
tracheal tube 7.0–7.5 in diameter, which was inserted by an
anaesthetist between the vocal folds under direct vision
during intubation. The standardized technique of
neuromonitoring of the RLNs was used, including indirect
vagal response evaluation at the beginning and at the end of
the operation (IONM = L1 ? V1 ? R1 ? R2 ? V2 ?
L2) according to the recommendations formulated recently
by the International Intraoperative Neural Monitoring
Study Group [14]. The nerves were stimulated using a
monopolar electrode and the interrupted stimulation tech-
nique at 1 mA, 100 ms impulse duration and 4 Hz fre-
quency. In case of bifurcated RLN nerves, the assessment
included post-stimulation response of each nerve branch
based on acoustic evaluation of the signal, EMG response
evaluation (latency and amplitude) and the technique of
posterior larynx palpation (‘laryngeal twitch’). After the
removal of the thyroid lobe, the indirect stimulation
(through the electrode placed on the ipsilateral vagus
nerve) response was determined and used to predict the
postoperative outcome.
The validity of nerve monitoring was defined and cal-
culated according to Chan and Lo [19]. A missing signal
was considered positive, predicting postoperative ipsilat-
eral vocal cord injury. The test result was regarded as true
positive when ipsilateral RLN paresis was confirmed on a
postoperative laryngoscopic examination and false positive
when normal ipsilateral vocal cord function was found. An
intact signal after the thyroidectomy was considered neg-
ative, predicting normal postoperative vocal cord function.
This was interpreted as true negative if there was normal
ipsilateral vocal cord function and false negative if there
was a postoperative laryngoscopic diagnosis of RLN
paresis.
Perioperative management and follow-up
Laryngoscopy (either indirect or direct videolaryngoscopy)
by a throat specialist was mandatory before surgery and on
day 1 after surgery. In patients with RLN paresis, an
additional examination was scheduled at 1, 2, 4, 6 and
12 months after surgery, or until the vocal cord function
was recovered. Vocal cord paresis for more than 12 months
after the operation was regarded as permanent palsy.
Statistical analysis
For a sample size calculation, an assumption was made that
the use of IONM as an addition to the gold standard of
visual identification of the RLN should reduce the preva-
lence of RLN injury by 50 % or more. To detect this, it was
calculated that 492 nerves at risk (NAR) would be required
in each treatment arm to give the study a power of 80 %
with p = 0.05 to reliably evaluate RLN injury reduction
from 6 to 3 %. The incidence of nerve events was calcu-
lated based on the number of NAR. Data are presented as
Table 2 Extent of surgery
With
IONM
(n = 306)
Without
IONM
(n = 548)
p value
NAR 500 826 NA
Bilateral/unilateral dissections
(ratio)a
194/112
(1.7)
278/270
(1.0)
\0.001
Surgical intervention
Total thyroidectomy 178 (58.2) 154 (28.1) \0.001
Near-total thyroidectomy 12 (3.9) 56 (10.2) 0.001
Bilateral subtotal
thyroidectomy
4 (1.3) 68 (12.4) \0.001
Lobectomy 110 (35.9) 201 (36.7) 0.831
Subcapsular lobectomy 2 (0.7) 69 (12.6) \0.001
Central neck dissection 31 (10.1) 48 (8.8) 0.507
Lateral neck dissection 16 (5.2) 27 (4.9) 0.847
Staged thyroidectomy in case
of LOS k
23 (7.5) Not used NA
Completion of staged
thyroidectomy in case of
LOS during first reoperation
k
11 (3.6) Not used NA
Data are presented as numbers (%)
k calculated for patients. v2 test for all
IONM intraoperative nerve monitoring, LOS loss of signal on the
dominant side (which was operated on first), NA not applicable, RLN
recurrent laryngeal nerve
a Patients with preoperative RLN paresis were calculated as unilat-
eral dissections if contralateral side of the neck was operated on
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mean (standard deviation) or mean (range), unless stated
otherwise. The statistical significance of categorical vari-
ables was evaluated using the v2 test, whereas the Students
t test was used for the analysis of continuous variables. All
data were collected prospectively, stored in a computer-
based institutional register of thyroid surgery and analysed
retrospectively by a statistician, assuming that p \ 0.05
was indicative of significance. Statistical analyses were
performed with Statistica 10 for Windows (StatSoft,
Kraków, Poland).
Results
Of 15,383 patients referred for thyroid surgery during the
study interval, 1,151 underwent reoperative thyroid surgery
and were potential candidates for the study. A total of 297
patients did not meet the inclusion criteria (completion
thyroidectomy for cancer in a patient after lobectomy 161;
contralateral goitre recurrence in a patient after lobectomy
87; incomplete clinical data 23 or follow-up information 19;
goitre recurrence in the pyramidal lobe in a patient after total
thyroidectomy 7), leaving 854 patients who were finally
included in this study. There were 715 women and 139 men,
with a mean age at diagnosis of 54.2 ± 13.4 years. The
IONM system became available at our unit in 2004 and, since
then, it has been utilized in both primary and reoperative
thyroid surgery with increasing frequency (Fig. 1). The
study group comprised 306 patients (194 bilateral and 112
unilateral reoperations; 500 NAR) who underwent reopera-
tive thyroid surgery with RLN visualization and IONM. The
Neurosign 100 system (Inomed, Teningen, Germany) was
used in reoperations of 108 patients treated in 2004–2007,
while the NIM 2.0 followed by the NIM 3.0 (Medtronic,
Jacksonville, USA) was used in reoperations of 198 patients
treated in 2008–2012. A group of 548 patients (278 bilateral
and 270 unilateral reoperations; 826 NAR) who had thyroid
reoperations with RLN visualization but without IONM
served as the control group. A clinical characteristics of the
patients analysed in this study is shown in Table 1; the extent
of surgery is shown in Table 2. Both median and mean
operative time was shorter for reoperations performed with
versus without IONM (80 and 88.3 ± 23.3 min vs. 100 and
94.5 ± 23.0 min; p \ 0.001).
Primary outcome measures analysis
In operations with RLN visualization plus additional
IONM, the prevalence of RLN injury, transient RLN
paresis and permanent RLN palsy was, respectively, 4.7 %
(p = 0.001), 3.7 % (p = 0.003) and 1.0 % (p = 0.202)
lower than with visualization alone. At 12-month follow-
up, 52 of 72 patients (72.2 %) having visualization alone
versus 13 of 20 (65.0 %) individuals having additional
IONM recovered their vocal cord function (median
4 months after surgery; range 2–12 months after surgery).
Details are shown in Table 3. No bilateral RLN palsy
occurred in patients reoperated with IONM, but it was a
sequel necessitating tracheostomy in one patient with
pre-existing contralateral RLN palsy who underwent
reoperation without IONM (0 vs. 0.2 %, respectively;
p = 0.455).
Fig. 1 Year-to-year
distribution of thyroid
reoperations with respect to use
of IONM among patients treated
in 1993–2012. No IONM
(n = 548), with IONM
(n = 306)
Table 3 Incidence of RLN injuries
Postoperative
laryngoscopy
NAR p value
With IONM
(n = 500)
Without IONM
(n = 826)
Paresis
Transient 13 (2.6) 52 (6.3) 0.003
Permanent 7 (1.4) 20 (2.4)a 0.202
Total paresis 20 (4.0) 72 (8.7)a 0.001
Data are presented as numbers (%)
v2 test for all
IONM intraoperative nerve monitoring, RLN recurrent laryngeal
nerve
a Bilateral RLN palsy occurred in one patient with pre-existing
contralateral RLN palsy who underwent reoperation without IONM
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Secondary outcome measures analysis
Utilization of the nerve mapping technique allowed for
localization of 97 (19.4 %) of the RLN nerves before visual
nerve exposition and almost twofold more ramified nerves
than RLN visualization alone: 99/826 (12.0 %) versus
107/500 (21.4 %); p \ 0.001. In addition, the non-RLN
was identified in 9 of 500 NAR (1.8 %) operated with
IONM versus 4 of 826 (0.5 %) NAR operated without
IONM; p = 0.02.
The value of IONM in predicting postoperative vocal
cord function was encouraging. The following predictive
values of the vagus stimulation (V2) at the end of surgery
were found for the entire cohort of 500 NAR operated with
IONM: NPV 99.6 %; PPV 78.3 %; and overall accuracy
98.6 %. Detailed data related to loss of signal predictive
values are presented in Table 4. In our experience, the NIM
2.0 or NIM 3.0 systems had similar NPV and overall
accuracy as the Neurosign 100 system (99.7 vs. 99.4 %
and 99.4 vs. 97.0 %, respectively), but better PPV (90.9 vs.
66.7 %, respectively).
Discussion
IONM has gained widespread acceptance as an adjunct to
the gold standard of visual nerve identification, and this
technique can be used to identify the RLN and the external
branch of the superior laryngeal nerve (EBSLN) in both
primary thyroid surgery and thyroid reoperations [11, 14,
15, 18, 20–23]. The nerve may be mapped out in the
operative field before visual identification, and additional
intermittent stimulation of adjacent non-neural tissue ver-
sus nerve can help in tracing the nerve and all its branches
through the dissected field. In addition, electric nerve
testing at the end of the operation can serve for postoper-
ative prognostication of nerve function [14]. In a pro-
spective, randomized study of 1,000 patients (1,000 NAR
per arm) published in 2009 by Barczyński et al. [17] the
prevalence of transient RLN paresis was significantly lower
in the group of patients who had primary thyroid surgery
with IONM (by 2.9 % in high-risk patients and by 0.9 % in
low-risk patients). The rate of permanent nerve palsy ten-
ded to be lower in operations performed with versus
without IONM (by 30 %), but the power of this study was
not sufficient to validate this difference. A more recent
study by the same authors published in 2012 showed that
the use of IONM significantly improved the identification
rate of the EBSLN during thyroidectomy, as well as
reduced the risk of early phonation changes after thyroid-
ectomy [22, 23].
A reoperation in the scar tissue of the central neck is more
dangerous for the RLN (and also for the parathyroid glands)
than a primary operation, and the utilization of IONM is
believed to aid in redo dissection, which should minimize the
risk of nerve injury. It is well known that the prevalence of
RLN injury after thyroid reoperations is variable (details are
shown in Table 5) and dependent on surgeons’ experience,
and hence it is lower in high-volume centres [8, 24, 25].
Despite the fact that thyroid reoperations have become less
common due to a wide acceptance of total thyroidectomy as a
standard treatment for benign thyroid disease in tertiary
referral centres, one-half of thyroid surgery worldwide is
performed in low-volume centres, in which subtotal thy-
roidectomy is still a common procedure [25]. In recent years,
the majority of patients undergoing thyroid reoperations in
our unit were referred from outside low-volume institutions;
n = 215 of 306 patients (70.3 %) undergoing surgery with
IONM in 2004–2012. Referring physicians recognized both
the experience with and the availability of the IONM system
at our institution as a guarantee of redo thyroid surgery being
performed as safely as possible. However, so far, this belief is
not entirely evidence based. It is well known that experience
and routine nerve exposure are crucial to minimization of
RLN complications [1, 2, 24, 25]. However, the IONM-
added value in reducing RLN-related morbidity in the re-
operative setting remains unclear. Yarbrough et al. [20]
employed IONM in 52 cervical re-exploration procedures
and found that it could be performed safely, but did not
decrease RLN morbidity. Alesina et al. [11] recently repor-
ted a retrospective series of 250 thyroid reoperations,
including 91 operations performed with IONM, and 159
surgeries with direct nerve visualization but without IONM,
and no significant differences were observed in this study in
the prevalence of RLN injury between both groups. Never-
theless, the outcomes of these studies could be influenced by
selection bias, as decision to use IONM was dependent on the
Table 4 Correlation of IONM results with postoperative outcomes
IONMa Postoperative
outcome (n)
Total
(n)
Predictive
value
%
RLN
paresis
No RLN
paresis
LOS (positive) 18 5 23 PPV 78.3
Intact signal
(negative)
2 475 477 NPV 99.6
Total 20 480 500 Accuracy 98.6
Operations were performed with Neurosign 100 (n = 108) and NIM
2.0 or NIM 3.0 systems (n = 198)
Accuracy TP ? TN/TP ? TN ? FP ? FN, IONM intraoperative
nerve monitoring, LOS loss of signal, RLN recurrent laryngeal nerve,
PPV positive predictive value (TP/TP ? FP), NPV negative predic-
tive value (TN/TN ? FN), TP true positive, TN true negative, FP
false positive, FN false negative
a Calculated for indirect stimulation through vagus nerve after thy-
roid resection (V2) and for NAR
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availability of the equipment and individual surgeon’s
preferences according to the planned extent of the surgical
procedure (a more liberal use of IONM in more challenging
dissections). On the other hand, these studies were based on
relatively small groups of patients, and statistical validation
of small differences in the prevalence of RLN injury requires
much bigger study arms.
As indicated by the results of our power calculation, 492
NAR are required in each treatment arm to give the study a
power of 80 % with p = 0.05 to reliably evaluate RLN
injury reduction from 6 to 3 %. The present study is the
largest comparative analysis of thyroid reoperations per-
formed with versus without IONM. It is important to stress
that the prevalence of transient RLN paresis was decreased
by almost 60 % in operations with RLN visualization plus
additional IONM than RLN visualization alone (2.5 vs.
6.3 %, respectively; p = 0.003). In addition, the prevalence
of permanent RLN palsy was 40 % lower in reoperations
with IONM than with RLN visualization alone, but this
difference was statistically not significant (p = 0.202).
Given the outcomes of this study, a sample size of 920 NAR
per arm was calculated as required to reliably assess the
difference in the prevalence of permanent RLN events.
The explanation of better outcomes achieved in thyroid
reoperations with IONM versus RLN visual identification
alone should include a few important issues. First, IONM
provided improved recognition of the anatomical details in
the scar tissues of the neck with the use of the nerve
mapping technique (almost 20 % of the RLNs were iden-
tified with IONM before visual exposition of the nerve, and
almost twofold more ramified nerves were identified in
reoperations with IONM). In addition, the rare but partic-
ularly prone to injury non-RLN was almost fourfold more
often identified in patients operated with versus without
IONM (p = 0.02). A lack of the initial vagus response
(V1) when stimulating below the inferior thyroid artery,
but positivity when stimulating above the inferior thyroid
artery in a patient with intact preoperative ipsilateral vocal
cord mobility, and a latency of the response shorter than
3.5 ms may alert the surgeon to the occurrence of this rare
variant of the nerve before any surgical dissection is
undertaken. This technique is of paramount importance in
avoiding inadvertent and in most cases unrecognized
intraoperative injury to the non-RLN [26, 27]. Second,
intermittent RLN stimulation during the operation allowed
for functional testing of the nerve. In case of EMG
amplitude decrease during the case amounting to a drop of
more than 30–50 % from the baseline value, even if the
RLN seemed to be anatomically intact, surgeons stopped
the dissection for a while and continued it with reduced
traction of the nerve, observing in most cases a spontane-
ous EMG signal recovery. Third, in case of a loss of signal
on the dominant side of the neck, which was, as a rule,
operated on first (defined as no EMG signal at all, or a
Table 5 RLN injury after reoperative thyroid surgery in published English-language series larger than 100 patients
Author Year Patients (n) NAR (n) Temporary RLN
injury (%)
Permanent RLN
palsy (%)
Reeve et al. [1] 1988 408 nd 6 (1.5)a nd
Levin et al. [2] 1992 114 nd 1 (0.9)a 1 (0.9)a
Seiler et al. [3] 1996 166 242 nd 10 (4.1)
Chao et al. [4] 1997 115 nd 3 (2.6)a 2 (1.7)a
Menegaux et al. [5] 1999 202 nd 5 (2.5)a 2 (1.0)a
Müller et al. [6] 2001 949 1,307 46 (3.5) 33 (2.5)
Gibelin et al. [7] 2004 122 nd 15 (12.3)a 1 (0.8)a
Lefevre et al. [8] 2007 685 nd 8 (1.2)a 10 (1.5)a
Calò et al. [9] 2012 106 174 5 (2.9) 1 (0.6)
Kurmann et al. [10] 2012 109 133 ipsilateral nd 5 (3.8)
33 contralateral nd 0 (0)
RLN injury without vs. with IONM Without vs.
with IONM
Without vs.
with IONM
Without vs.
with IONM
Alesina et al. [11] 2012 246 161 vs. 128 4 (2.5) vs. 8 (6.2) 1 (0.6) vs. 0 (0)
Present study 2013 836 826 vs. 500 52 (6.3) vs. 13 (2.6) 20 (2.4) vs. 7 (1.4)
Data are presented as numbers (%) unless otherwise indicated
Calculation for NAR unless otherwise indicated
IONM intraoperative nerve monitoring, nd no data, RLN recurrent laryngeal nerve
 p = 0.003
a Calculation for patients, not for NAR
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weak EMG waveform amplitude of less than 100 lV after
ipsilateral vagus stimulation), the contralateral thyroid
reoperation was staged for both benign (n = 20) and
malignant disease (n = 3). Contralateral thyroid surgery
was undertaken afterwards when ipsilateral vocal fold
mobility was restored (n = 11). Two patients refused to
undergo completion thyroidectomy after staged procedure
for loss of signal. Details are shown in Tables 2, 3 and 4. In
general, contralateral thyroid surgery was avoided in
patients with benign thyroid disease and the only func-
tioning RLN (permanent palsy), but it was undertaken in
selected patients with contralateral loco-regional recur-
rence of thyroid cancer. The concept of staged thyroidec-
tomy was proven to be effective in preventing bilateral
RLN injury [28, 29], which is particularly important in
bilateral thyroid reoperations and has been accepted by
many [18, 30], but not all, thyroid surgeons [31]. The
opponents of staged thyroidectomy indicate that PPV of
IONM is relatively low (varying from 50 to 75 % in the
majority of reported series), which can result in unneces-
sary staging of operation in 25–50 % of patients who
experience loss of signal on the first side, but have no
ipsilateral RLN paresis [31]. In this study, PPV of IONM
was within the upper limits of the reported values (see
Table 4), and it was better for the systems based on EMG
waveform analysis (90.9 %) than for simple nerve stimu-
lators with acoustic signalling (66.7 %). Thus, further
improvements in PPV can be expected with utilization of
continuous IONM, based on automatic permanent stimu-
lation of the vagus nerve and almost real-time monitoring
of the EMG quantitative parameters during surgery [32]. It
should be also recognized that a cost-effectiveness analysis
of the routine utilization of IONM in thyroid reoperations
has never been reported and was also out of scope for this
study; this issue needs to be clarified in future.
In conclusion, in our hands, IONM decreased the inci-
dence of transient RLN paresis in repeat thyroid operations
as compared with nerve visualization alone. The preva-
lence of permanent RLN injury tended to be lower in
reoperations with IONM. However, given the outcomes of
this study, a sample size of 920 NAR per arm is required to
reliably assess a difference in the prevalence of permanent
RLN events. Experience and routine nerve exposure
remain crucial to the minimization of RLN complications
in thyroid reoperations, but the use of the lateral approach
with mapping of the RLN low in the neck and tracing its
path in the scar tissues towards the larynx may provide
additional benefits: an improved recognition rate of the
ramified or non-recurrent nerves, and functional RLN
testing feedback alerting the surgeon to a possible
stretching injury of the nerve, particularly in the region of
the ligament of Berry [33].
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